These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 35572939)

  • 1. Case Report: Exacerbation of Relapses Following mRNA COVID-19 Vaccination in Multiple Sclerosis: A Case Series.
    Quintanilla-Bordás C; Gascón-Gimenez F; Alcalá C; Payá M; Mallada J; Silla R; Carratalà-Boscà S; Gasque-Rubio R; Castillo J; Casanova B
    Front Neurol; 2022; 13():897275. PubMed ID: 35572939
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Incidence of multiple sclerosis relapses and pseudo-relapses following COVID-19 vaccination.
    Labani A; Chou S; Kaviani K; Ropero B; Russman K; Becker D
    Mult Scler Relat Disord; 2023 Sep; 77():104865. PubMed ID: 37418929
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Case of Multiple Sclerosis Uncovered Following Moderna SARS-CoV-2 Vaccination.
    Ahoussougbemey Mele A; Ogbuagu H; Parag S; Pierce B
    Cureus; 2022 Dec; 14(12):e32799. PubMed ID: 36694492
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Case Report: Multiple Sclerosis Relapses After Vaccination Against SARS-CoV2: A Series of Clinical Cases.
    Nistri R; Barbuti E; Rinaldi V; Tufano L; Pozzilli V; Ianniello A; Marinelli F; De Luca G; Prosperini L; Tomassini V; Pozzilli C
    Front Neurol; 2021; 12():765954. PubMed ID: 34744992
    [No Abstract]   [Full Text] [Related]  

  • 5. Myoclonus status revealing COVID 19 infection.
    Ben Mohamed D; Zouari R; Ketata J; Nabli F; Blel S; Ben Sassi S
    Seizure; 2023 Jan; 104():12-14. PubMed ID: 36446232
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acute Multiple Sclerosis Exacerbation After Vaccination With the Johnson & Johnson COVID-19 Vaccine: Novel Presentation and First Documented Case Report.
    Al-Midfai Y; Kujundzic W; Uppal S; Oakes D; Giezy S
    Cureus; 2022 Apr; 14(4):e24017. PubMed ID: 35547449
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Seropositive Neuromyelitis Optica in a Case of Undiagnosed Ankylosing Spondylitis: A Neuro-Rheumatological Conundrum.
    Ghosh Md R; Roy D; León-Ruiz M; Das S; Dubey S; Benito-León J
    Qatar Med J; 2022; 2022(3):29. PubMed ID: 35864917
    [TBL] [Abstract][Full Text] [Related]  

  • 8. COVID-19 mRNA vaccination leading to CNS inflammation: a case series.
    Khayat-Khoei M; Bhattacharyya S; Katz J; Harrison D; Tauhid S; Bruso P; Houtchens MK; Edwards KR; Bakshi R
    J Neurol; 2022 Mar; 269(3):1093-1106. PubMed ID: 34480607
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multiple sclerosis relapse after COVID-19 vaccination: A case report-based systematic review.
    Nabizadeh F; Ramezannezhad E; Kazemzadeh K; Khalili E; Ghaffary EM; Mirmosayyeb O
    J Clin Neurosci; 2022 Oct; 104():118-125. PubMed ID: 36029752
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association between history of SARS-CoV-2 infection and severe systemic adverse events after mRNA COVID-19 vaccination among U.S. adults.
    Tompkins LK; Baggs J; Myers TR; Gee JM; Marquez PL; Kennedy SB; Peake D; Dua D; Hause AM; Strid P; Abara W; Rossetti R; Shimabukuro TT; Shay DK
    Vaccine; 2022 Dec; 40(52):7653-7659. PubMed ID: 36372665
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 2: Epidemiology, clinical presentation, radiological and laboratory features, treatment responses, and long-term outcome.
    Jarius S; Ruprecht K; Kleiter I; Borisow N; Asgari N; Pitarokoili K; Pache F; Stich O; Beume LA; Hümmert MW; Ringelstein M; Trebst C; Winkelmann A; Schwarz A; Buttmann M; Zimmermann H; Kuchling J; Franciotta D; Capobianco M; Siebert E; Lukas C; Korporal-Kuhnke M; Haas J; Fechner K; Brandt AU; Schanda K; Aktas O; Paul F; Reindl M; Wildemann B;
    J Neuroinflammation; 2016 Sep; 13(1):280. PubMed ID: 27793206
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safety of COVID-19 vaccines in multiple sclerosis: A systematic review and meta-analysis.
    Stefanou MI; Palaiodimou L; Theodorou A; Christodoulou MV; Tzartos JS; Tzanetakos D; Kitsos D; Chondrogianni M; Zouvelou V; Dardiotis E; Tzavellas E; Syrigou E; Benetou V; Paraskevas GP; Tsiodras S; Tsivgoulis G; Giannopoulos S
    Mult Scler; 2023 Apr; 29(4-5):585-594. PubMed ID: 36722184
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Severe disease exacerbation after mRNA COVID-19 vaccination unmasks suspected multiple sclerosis as neuromyelitis optica spectrum disorder: a case report.
    Lohmann L; Glaser F; Möddel G; Lünemann JD; Wiendl H; Klotz L
    BMC Neurol; 2022 May; 22(1):185. PubMed ID: 35585528
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multiple Sclerosis Relapse Following COVID-19 Vaccination: A Case Report and Literature Review.
    Kataria S; Rogers S; Bilal U; Baktashi H; Singh R
    Cureus; 2022 Jan; 14(1):e21374. PubMed ID: 35198286
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MOG Antibody-Associated Disorders Following SARS-CoV-2 Vaccination: A Case Report and Literature Review.
    Matsumoto Y; Ohyama A; Kubota T; Ikeda K; Kaneko K; Takai Y; Warita H; Takahashi T; Misu T; Aoki M
    Front Neurol; 2022; 13():845755. PubMed ID: 35299613
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Safety and humoral response rate of inactivated and mRNA vaccines against SARS-CoV-2 in patients with Multiple Sclerosis.
    Ciampi E; Uribe-San-Martin R; Soler B; García L; Guzman J; Pelayo C; Jürgensen L; Guzman I; Vera F; Galleguillos L; Cárcamo C
    Mult Scler Relat Disord; 2022 Mar; 59():103690. PubMed ID: 35182880
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of the COVID-19 pandemic on disease activity in multiple sclerosis patients treated with hematopoietic stem cell transplantation.
    Mariottini A; Lotti A; Innocenti C; Repice AM; Nozzoli C; Boncompagni R; Fainardi E; Saccardi R; Massacesi L
    Eur J Neurol; 2023 Oct; 30(10):3362-3366. PubMed ID: 37483174
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Case report: First manifestation of multiple sclerosis temporally correlated with COVID-19 vaccination.
    Czarnowska A; Kapica-Topczewska K; Tarasów E; Tarasiuk J; Chorąży M; Kochanowicz J; Kułakowska A
    Front Neurol; 2023; 14():1097799. PubMed ID: 36873437
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multiple Sclerosis and Neuromyelitis Optica Spectrum Disorder: Onset Following Acute COVID-19 Infection, a Case Series.
    Avila M; Tan Y; Hernandez R; Zuberi H; Rivera VM
    Neurol Ther; 2023 Feb; 12(1):319-327. PubMed ID: 36399224
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Miller Fisher syndrome following BNT162b2 mRNA coronavirus 2019 vaccination.
    Nishiguchi Y; Matsuyama H; Maeda K; Shindo A; Tomimoto H
    BMC Neurol; 2021 Nov; 21(1):452. PubMed ID: 34789193
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.